| FDA Welcomes Variety of Phase 2/3 Trial Designs for COVID-19 Therapies | Bridget Silverman | 05/28/20 | National |
| Antibiotic Development: HHS Not Yet Sold on “Pull” Incentives | Sarah Karlin-Smith | 05/16/20 | National |
| White House Floats Canadian Import Plan But Excludes Many Costly Drugs | Frank Vinluan | 07/31/19 | National |
| Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More | Frank Vinluan | 02/01/19 | National |
| Stratatech Gets $26M More to Develop Skin Tissue for Treating Burns | Jeff Buchanan | 10/16/18 | Wisconsin |
| Bio Roundup: Pfizer’s Prices, Novartis Cuts, Gene Therapy Guide & More | Frank Vinluan | 07/13/18 | National |
| Senators Grill HHS’s Azar on Drug Price Cuts That Have Yet to Come | Frank Vinluan | 06/26/18 | National |
| Trump Pledges Lower Drug Prices, But Blueprint Is Short on Details | Ben Fidler | 05/11/18 | National |
| With New Test, Schadt’s Sema4 Aims to Broaden Scope of Newborn Screening | Ben Fidler | 02/07/18 | New York |
| Q&A: Dell Med’s DeSalvo Talks Social Health Startups, Data Ownership | Jeff Buchanan | 01/19/18 | National |
| Bio Roundup: Migraine Data, Cancer Drug Combos, Azar Hearing & More | Frank Vinluan | 12/01/17 | National |
| Brett Giroir, Ex-CEO of A&M Health Science Center, on Tap for HHS Post | Angela Shah | 05/15/17 | Texas |
| Bio Roundup: Trump Budget, FDA Chief, CAR-T Qs, CRISPR Cash, & More | Alex Lash | 03/17/17 | National |
| Trump Policies, Paperwork, & More: Advice for Startup Founders | Jeff Buchanan | 02/24/17 | Wisconsin |
| Senate Confirms Price for HHS, But Stock Deals Still Raise Questions | Frank Vinluan | 02/10/17 | National |
| Often Advocates Of Faster FDA, Patient Groups Wary Of Trump Deregulation | Alex Lash | 02/10/17 | National |
| Bio Roundup: Travel Ban, Pharma in DC, Biogen Splits, PCSK9 Wins | Ben Fidler | 02/03/17 | National |
| Bio Roundup: Tom Price, Patient Conflicts, Orphan Games & More | Alex Lash | 01/20/17 | National |
| This Week in Drug Pricing and Post-Election Healthcare Policy News | Ben Fidler | 12/02/16 | National |
| Bio Roundup: CAR-T Ups & Downs, Lilly’s Failure, Myeloma & More | Ben Fidler | 12/02/16 | National |
| Salvaged From Bankruptcy, TranS1 Medical Device Finds New Life | Frank Vinluan | 11/17/15 | Raleigh Durham |
| NuVasive CEO Resigns After Probe of Personnel and Policy Violations | Bruce V. Bigelow | 04/01/15 | San Diego |
| An Intriguing Program Takes on Tropical Diseases—But Not Ebola | Alex Lash | 09/10/14 | National |
| West Coast Biotech Roundup: Mapp Bio, Calico, Alder, VentiRx & More | Alex Lash | 09/04/14 | San Diego |
| U.S. CTO Todd Park Out to Spur Entrepreneurship With Data “Jujitsu” | Robert Buderi | 09/10/12 | National |
| drchrono’s iPad App for Doctors Wins “Meaningful Use” Certification | Wade Roush | 07/28/11 | San Francisco |
| Aneesh Chopra, Obama’s Chief Technology Officer, Talks About Health IT Geek Squads, Entrepreneurship Prizes, and “Data as a Policy Lever” | Wade Roush | 10/07/10 | San Francisco |
| PATH Snaps Up $5M Contract to Make Flu Vaccines For Stockpiling, Hot Conditions | Luke Timmerman | 09/15/10 | Seattle |
| Biotech’s Second Big Win in Healthcare Reform: A Tax Credit Bonanza | Stewart Lyman | 04/08/10 | National |
| Daily TIPs: Will Wi-Fi Rule?, Blogging from the Top, Nanotech Safety, & More | Neil Savage | 07/30/08 | National |
